Half Year 2024 Novozymes A/S Earnings Call TranscriptAug 28, 2024kr462.1 (+1.56%)Earnings- Novozymes A/S 2024 Outlook and 2023 Pro Forma Financials Call TranscriptMar 21, 2024
- Novozymes A/S Extraordinary Shareholders Meeting TranscriptMar 04, 2024
- Q4 2023 Novozymes A/S Earnings Call TranscriptFeb 01, 2024kr371.6 (+4.88%)Earnings
- Q3 2023 Novozymes A/S Earnings Call TranscriptOct 26, 2023kr299.9 (+7.96%)Earnings
- Q2 2023 Novozymes A/S Earnings Call TranscriptAug 09, 2023kr327.7Earnings
- Q1 2023 Novozymes A/S Earnings Call TranscriptApr 26, 2023kr355.2 (-3.53%)Earnings
- Novozymes A/S Annual Shareholders Meeting TranscriptMar 02, 2023
- Q4 2022 Novozymes A/S Earnings Call TranscriptJan 26, 2023kr348.3 (-0.68%)Earnings
- Novozymes A/S and Chr Hansen Holding A/S to Discuss Agreement to Combine Through a Statutory Merger Call TranscriptDec 12, 2022
- Q3 2022 Novozymes A/S Earnings Call TranscriptNov 03, 2022kr395 (+1.28%)Earnings
- Q2 2022 Novozymes A/S Earnings Call TranscriptAug 11, 2022kr452.5 (+3.00%)Earnings
- Novozymes A/S Spotlight on Human Health Presentation TranscriptJun 17, 2022
- Q1 2022 Novozymes A/S Earnings Call TranscriptApr 27, 2022kr483.2 (+2.83%)Earnings
- Novozymes A/S Annual Shareholders Meeting TranscriptMar 16, 2022
- Q4 2021 Novozymes A/S Earnings Call TranscriptFeb 01, 2022kr441 (-2.63%)Earnings
- Q3 2021 Novozymes A/S Earnings Call TranscriptOct 27, 2021kr472 (+0.62%)Earnings
- Novozymes A/S Capital Markets Day (Virtual) TranscriptSep 28, 2021
- Q2 2021 Novozymes A/S Earnings and to Discuss Investment Into Advanced Protein Solutions Call TranscriptAug 12, 2021
- Q1 2021 Novozymes A/S Earnings Call TranscriptApr 27, 2021kr444.7 (+5.58%)Earnings
- Novozymes A/S Annual Shareholders Meeting TranscriptMar 11, 2021
- Q4 2020 Novozymes A/S Earnings Call TranscriptFeb 02, 2021kr373.4 (-0.69%)Earnings
- Q3 2020 Novozymes A/S Earnings Call TranscriptOct 21, 2020kr392.5 (-5.38%)Earnings
- Q2 2020 Novozymes A/S Earnings Call TranscriptAug 12, 2020kr368.9 (-3.76%)Earnings
- Q2 2020 Novozymes A/S Trading Update Call TranscriptJul 08, 2020
- Q1 2020 Novozymes A/S Earnings Call TranscriptApr 29, 2020kr326.2 (+2.35%)Earnings
- Q1 2020 Novozymes A/S Organic Sales Call TranscriptApr 07, 2020
- Novozymes A/S Annual Shareholders Meeting TranscriptFeb 26, 2020
- Q4 2019 Novozymes A/S Earnings Call TranscriptJan 23, 2020kr351.4 (+6.65%)Earnings
- Q3 2019 Novozymes A/S Earnings Call TranscriptOct 23, 2019kr304.3 (+4.93%)Earnings
- Novozymes A/S to Discuss the Adjusted FY 2019 Outlook Call TranscriptOct 10, 2019
- Q2 2019 Novozymes A/S Earnings Call TranscriptAug 08, 2019kr288.8 (-4.31%)Earnings
- Novozymes A/S Capital Markets Day 2019 TranscriptJun 17, 2019
- Q1 2019 Novozymes A/S Earnings Call TranscriptApr 24, 2019kr309 (-2.49%)Earnings
- Novozymes A/S to Discuss the Continuation of Partnership with Bayer AG and with Two New Partners, Univar Solutions and UPL Ltd Call TranscriptApr 05, 2019
- Novozymes A/S Annual Shareholders Meeting TranscriptFeb 27, 2019
Q4 2023 Novozymes A/S Earnings Call Transcript
Welcome to the Novozymes 2023 Results. (Operator Instructions) Today, I'm pleased to leave the word to Tobias Cornelius Björklund, Head of Investor Relations. Please begin your meeting.
/-
Thank you, operator, and welcome, everyone, to Novozymes conference call for 2023. So my name is Tobias Björklund, as mentioned, and I'm the Head of Investor Relations at Novozymes and now Novonesis.
At this call, our CEO, Ester Baiget; and our CFO, Rainer Lehmann, will review Novozymes' 2023 unaudited performance and key events of the year. Also attending today's calls are Tina Fanø, EVP, Agriculture & Industrial Biosolutions; Amy Byrick, EVP Strategy & Business Transformation; Anders Lund, EVP Consumer Biosolutions; and Claus Fuglsang, CSO and EVP of Research and Development, all in Novozymes.
The entire call will take about 50 minutes, including time for questions at the end.
As always, I would like to remind you that the information presented during
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
